Literature DB >> 21810970

Allogeneic stem cell transplantation for adult acute lymphoblastic leukemia: when and how.

Josep-Maria Ribera.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21810970      PMCID： PMC3148898          DOI： 10.3324/haematol.2011.048348

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  41 in total

1.  Favorable outcome of unrelated cord blood transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Yasushi Onishi; Osamu Sasaki; Satoshi Ichikawa; Kyoko Inokura; Yuna Katsuoka; Rie Ohtsuka Ohba; Yoko Okitsu; Katsura Kohata; Hiroto Ohguchi; Noriko Fukuhara; Hisayuki Yokoyama; Minami Fujiwara Yamada; Joji Yamamoto; Kenichi Ishizawa; Junichi Kameoka; Hideo Harigae
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-28       Impact factor: 5.742

Review 2.  Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Authors:  M Brüggemann; A Schrauder; T Raff; H Pfeifer; M Dworzak; O G Ottmann; V Asnafi; A Baruchel; R Bassan; Y Benoit; A Biondi; H Cavé; H Dombret; A K Fielding; R Foà; N Gökbuget; A H Goldstone; N Goulden; G Henze; D Hoelzer; G E Janka-Schaub; E A Macintyre; R Pieters; A Rambaldi; J-M Ribera; K Schmiegelow; O Spinelli; J Stary; A von Stackelberg; M Kneba; M Schrappe; J J M van Dongen
Journal:  Leukemia       Date:  2009-12-24       Impact factor: 11.528

Review 3.  Philadelphia chromosome-positive acute lymphoblastic leukemia: current treatment and future perspectives.

Authors:  Hun J Lee; James E Thompson; Eunice S Wang; Meir Wetzler
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

4.  Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

Authors:  Mary Eapen; Vanderson Rocha; Guillermo Sanz; Andromachi Scaradavou; Mei-Jie Zhang; William Arcese; Anne Sirvent; Richard E Champlin; Nelson Chao; Adrian P Gee; Luis Isola; Mary J Laughlin; David I Marks; Samir Nabhan; Annalisa Ruggeri; Robert Soiffer; Mary M Horowitz; Eliane Gluckman; John E Wagner
Journal:  Lancet Oncol       Date:  2010-07       Impact factor: 41.316

5.  Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997-2006.

Authors:  Gunnar Juliusson; Karin Karlsson; Vladimir Lj Lazarevic; Anders Wahlin; Mats Brune; Petar Antunovic; Asa Derolf; Hans Hägglund; Holger Karbach; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Helene Hallböök; Martin Höglund
Journal:  Cancer       Date:  2011-03-08       Impact factor: 6.860

Review 6.  Transplantation in adult ALL.

Authors:  Anthony H Goldstone; Jacob M Rowe
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

7.  Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.

Authors:  Anthony S Stein; Joycelynne M Palmer; Margaret R O'Donnell; Neil M Kogut; Ricardo T Spielberger; Marilyn L Slovak; Ni-Chun Tsai; David Senitzer; David S Snyder; Sandra H Thomas; Stephen J Forman
Journal:  Biol Blood Marrow Transplant       Date:  2009-11       Impact factor: 5.742

8.  Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen.

Authors:  Ginna G Laport; Joseph C Alvarnas; Joycelynne M Palmer; David S Snyder; Marilyn L Slovak; Athena M Cherry; Ruby M Wong; Robert S Negrin; Karl G Blume; Stephen J Forman
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

9.  Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.

Authors:  Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Pulsipher; Peter A McSweeney; Rainer Storb
Journal:  Cancer       Date:  2008-05-01       Impact factor: 6.860

10.  UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia.

Authors:  Adele K Fielding; Jacob M Rowe; Georgina Buck; Letizia Foroni; Gareth Gerrard; Mark R Litzow; Hillard Lazarus; Selina M Luger; David I Marks; Andrew K McMillan; Anthony V Moorman; Bella Patel; Elisabeth Paietta; Martin S Tallman; Anthony H Goldstone
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113
View more
  7 in total

1.  High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.

Authors:  Piotr Kozlowski; Maria Åström; Lucia Ahlberg; Per Bernell; Erik Hulegårdh; Hans Hägglund; Karin Karlsson; Alicja Markuszewska-Kuczymska; Beata Tomaszewska-Toporska; Bengt Smedmyr; Helene Hallböök
Journal:  Haematologica       Date:  2012-04-17       Impact factor: 9.941

2.  Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.

Authors:  M Eefting; C J M Halkes; L C de Wreede; C M van Pelt; S Kersting; E W A Marijt; P A von dem Borne; R Willemze; H Veelken; J H F Falkenburg
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

3.  Early and Late Complications in Patients with Allogeneic Transplantation of Hematopoietic Stem Cell - Case Report.

Authors:  Ivana Trajkovska; Borce Georgievski; Lidija Cevreska; Andrijana Gacovski; Taner Hasan; Natasha Nedeska-Minova
Journal:  Open Access Maced J Med Sci       Date:  2017-05-09

4.  Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients.

Authors:  Brice Jabo; John W Morgan; Maria Elena Martinez; Mark Ghamsary; Matthew J Wieduwilt
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

5.  A Comparison of Dexamethasone Plus Vincristine versus Standard Regimen in Induction Therapy of Adult Acute Lymphoblastic Leukemia Patients Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Mohammad Vaezi; Amirhoushang Pourkhani; Amir Kasaeian; Maryam Souri; Marjan Yaghmaie; Bahram Chardouli; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2022-01-01

6.  A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature.

Authors:  Chatree Chai-Adisaksopha; Alfonso Iorio; Christopher Hillis; Wendy Lim; Mark Crowther
Journal:  BMC Hematol       Date:  2016-06-08

7.  Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.

Authors:  Zhe Ding; Ming-Zhe Han; Shu-Lian Chen; Qiao-Ling Ma; Jia-Lin Wei; Ai-Ming Pang; Xiao-Yu Zhang; Chen Liang; Jian-Feng Yao; Yi-Geng Cao; Si-Zhou Feng; Er-Lie Jiang
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.